Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.
This editorial provides an insight into the advancing field of microsampling as a tool to monitor critically ill patients in the clinic, highlighting the need for further development to ensure patients receive the highest quality of care.
The speakers from our January panel discussion on immunogenicity answer further questions from the live event
A novel protein has been discovered that could be a useful blood-based biomarker to monitor the progression of inherited Alzheimer’s disease, over a decade before the clinical symptoms appear.
Researchers from Queen’s University Belfast (UK) have developed a new enzyme biomarker test that has the potential to detect disease and infection.
Researchers have used mass spectrometry to analyze blister fluid in order to aid the diagnosis of burn severity.
A new molecular engineering method, termed TAC-seq, has been developed to enhance the precision of clinical biomarker analysis.
Find out more about the current research focuses at KCAS Bioanalytical & Biomarker Services and how the industry has evolved over the last 5–10 years in this interview with John Bucksath (KCAS).
A small implantable device using LEDs has been developed to treat bladder problems, with the potential to replace current medications and electronic stimulators.
Find out more about the latest news in cardiovascular research including the development of disease biomarkers and cardiomyocyte sensors in this round-up.